Health care giants are trimming jobs, not driving employment growth
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
Molecular Adaptations And Engineering Of Extremophiles For Synthetic Biology And Biotechnological Applications
Industrial applications and role in the climate change of different classes of extremophiles. (a) Illustrations in the inner…
Readout Newsletter: Eli Lilly’s ‘triple-G’ drug delivers striking results
Regulators are trying to push drug development into a post-animal testing era. Meanwhile, a Jennifer Doudna-founded company is…
Tricorder Tech: Protein Sequencing Advance Offers New Insights Into Life’s Foundations
DNA-encoded Edman degradation on magnetic beads. (A) Reaction scheme for barcoding PTC amino acids via DNA-encoded Edman degradation…
With Evo 2, AI Can Model And Design The Genetic Code For All Domains Of Life
Mechanistic interpretability of Evo 2 reveals DNA, RNA, protein and organism-level features — Nature The DNA foundation model…
Zealand stock plummets after trial setback, CEO remains optimistic
Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management…
Engineered lettuce may turn injectable GLP-1 therapies into oral pills
Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…
TrumpRx: High expectations, but limited impact a month after launch
WASHINGTON — President Trump heralded his signature drug discount platform, TrumpRx, as “one of the most transformative health…
Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference
NEW YORK – February 25, 2026 Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage…
Jennifer Doudna’s journey from student to scientist and mentor
Key Insights Jennifer Doudna’s work uncovering the gene-editing capabilities of CRISPR has helped cure genetic diseases and…